The tumor stroma can drive cancer progression, although the mechanisms governing these effects are incompletely understood. their mechanism of action may provide an untapped target for cancer treatment. The 4 members of the tissue inhibitor Dinaciclib novel inhibtior of metalloproteinases (Timp) family control extracellular matrix (ECM) remodeling and the cell surface protein landscape through functional… Continue reading The tumor stroma can drive cancer progression, although the mechanisms governing